Medscape (7/5, Swift Yasgur , Subscription Publication) reported, “Early in-hospital administration of long-acting injectable (LAI) antipsychotics following a first admission for schizophrenia is linked to a significantly lower risk for hospital readmission, new research suggested.” Researchers “found that readmission rates increased in those who received LAIs with early discontinuation and decreased among their counterparts who received LAIs without early discontinuation compared with patients not receiving LAIs.” The findings were published in JAMA Network Open.
Related Links:
— Medscape (requires login and subscription)